Votrient (pazopanib) reaches peak levels in your blood within 2 to 3 hours of taking a dose, but that’s not the same as seeing results. The drug needs about three weeks to build up to its full steady-state concentration, and your oncologist will typically order the first scan to check for tumor response after about 12 weeks of treatment.
How Quickly Votrient Enters Your System
After swallowing an 800 mg dose, Votrient reaches its highest concentration in the bloodstream within about 3 hours on day one. As you continue taking it daily, absorption becomes slightly faster, with peak levels arriving at around 2 hours per dose. By day 22, the drug reaches what’s called steady state, meaning it has built up to a consistent therapeutic level that your body maintains from one dose to the next.
This three-week buildup period is when the drug begins exerting its full biological effect. Votrient works by blocking the signals that tumors use to grow new blood vessels. Starving the tumor of its blood supply doesn’t shrink it overnight. It’s a gradual process that plays out over weeks to months.
When You’ll Know If It’s Working
The first imaging scan, usually a CT scan, is typically scheduled after about 12 weeks (three cycles of four weeks each). This is the earliest point at which doctors can reliably measure whether tumors have shrunk or stabilized. In clinical trials for soft tissue sarcoma, 47% of patients on Votrient alone had no disease progression at that 12-week mark.
For kidney cancer, the median duration of treatment in clinical trials was 7.4 months, meaning half of patients stayed on the drug longer than that before their disease progressed or side effects became unmanageable. For soft tissue sarcoma, that median was shorter at 4.5 months. These numbers give you a rough sense of how long the drug tends to remain effective, though individual experiences vary widely.
Early Signs the Drug Is Active
One indirect signal that Votrient is doing its job can show up well before any scan. Because the drug blocks blood vessel growth, it often raises blood pressure, sometimes within the first four weeks. Studies have found a strong correlation between blood pressure increases and drug concentration levels in the blood. Some oncologists view early-onset high blood pressure as a pharmacological sign that the drug is reaching effective levels, though this relationship is still debated as a formal predictor of tumor response.
If your blood pressure rises after starting Votrient, your care team may add or adjust blood pressure medication. This is a manageable side effect and not a reason to stop treatment.
What to Expect for Quality of Life
Real-world data from kidney cancer patients treated with Votrient in community oncology settings showed that quality-of-life scores remained stable over time. Patients did not report meaningful worsening in areas like pain, fatigue, or overall well-being. This is worth knowing because some cancer treatments cause significant declines in daily functioning. Votrient appears to hold the line on quality of life for most patients, even if it doesn’t dramatically improve cancer-related symptoms in the short term.
Why Taking It on an Empty Stomach Matters
The standard dose is 800 mg once daily, taken at least one hour before or two hours after eating. Food significantly changes how the drug is absorbed. One clinical study found that taking a lower 600 mg dose with food produced blood levels equivalent to the standard 800 mg fasted dose. This matters because consistent absorption keeps the drug at the right therapeutic level. If you take it with a meal one day and without food the next, your blood levels will fluctuate unpredictably.
If side effects become difficult to manage, your oncologist can reduce the dose in steps rather than stopping the drug entirely. For kidney cancer, the first reduction drops to 400 mg daily. For soft tissue sarcoma, it drops to 600 mg. A second reduction is available if needed. These adjustments let you stay on treatment longer while keeping side effects tolerable, which directly affects how much time the drug has to work against the tumor.
A Realistic Timeline
Putting it all together, here’s what the trajectory looks like:
- Hours 2 to 3: The drug reaches peak blood levels after your first dose.
- Week 3: Steady-state concentration is reached, meaning the drug is at full therapeutic strength.
- Week 4: Blood pressure changes and other early pharmacological effects may appear.
- Week 12: First imaging scan to assess tumor response.
The hardest part for many patients is the uncertainty during those first three months. The drug is working at a biological level well before any scan can confirm it, but there’s no way to feel that process happening. Staying consistent with your daily dose and timing gives Votrient the best chance to reach and maintain effective levels in your body.